New test for airway inflammation after allergen challenge in mild asthma
Part of Lungs & breathing clinical trials.
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have mild asthma that is well controlled using only a rescue inhaler (no daily controller meds).
- You are a non-smoker (or quit more than a year ago and smoked less than a pack a day for a year).
- You have a known allergy to common triggers like pollen or dust mites, confirmed by a skin test.
- You have not taken steroids (pills or inhalers) for asthma in the last 4 weeks.
- You have not had a respiratory infection or asthma flare-up in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new inhaled medicine, ADO-5030, to see if it helps people with mild or moderate asthma when their airways narrow (bronchoconstriction). You will be asked to breathe in a substance that can trigger asthma symptoms, and the study will check if the medicine helps prevent or reduce that reaction.
This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.
This study looks at brain inflammation in people with mild asthma who are also allergic to common triggers like cats, dust mites, or ragweed. It uses MRI scans to see if a certain brain cell activity is different, which may help us understand asthma better and lead to new treatments.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This study tests whether a single dose of tiotropium (a medicine that helps open airways) can reduce the immediate reaction to allergens in people with mild asthma. If it works, it might offer a new way to prevent asthma attacks triggered by allergens.
Hear when a new Mild Allergic Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.